Phase III, National, Multicenter, Randomized, Single-blind, Non-inferiority to Compare the Efficacy of Mometasone Nasal Gel Compared to Mometasone Nasal Spray in the Treatment of Persistent or Intermittent Allergic Rhinitis in Childrens

Next Previous
Trial Profile

Phase III, National, Multicenter, Randomized, Single-blind, Non-inferiority to Compare the Efficacy of Mometasone Nasal Gel Compared to Mometasone Nasal Spray in the Treatment of Persistent or Intermittent Allergic Rhinitis in Childrens

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 09 Jan 2018

At a glance

  • Drugs Mometasone (Primary) ; Mometasone
  • Indications Allergic rhinitis
  • Focus Therapeutic Use
  • Sponsors EMS

    • Most Recent Events

    • 03 Jan 2018 Planned End Date changed from 1 May 2018 to 1 May 2020.
    • 03 Jan 2018 Planned primary completion date changed from 1 Feb 2018 to 1 Dec 2019.
    • 03 Jan 2018 Planned initiation date changed from 1 Sep 2017 to 1 May 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top